Serum phosphorus levels and fracture following renal transplantation
- 1 June 2017
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 87 (2) , 141-148
Abstract
Summary: Purpose: Increased fracture rates are observed in renal transplant recipients (RTRs) compared with the general population. Risk factors include age, diabetes, dialysis vintage, immunosuppression and mineral and bone disorders.1 Low serum phosphorus levels occur post‐transplantation; however, its relationship with fracture risk has not been evaluated. The purpose of this study was to evaluate risk factors for fracture in RTRs at a single tertiary referral centre.Methods: A retrospective cross‐sectional analysis of 146 patients (75 M, 71 F) who had been referred for dual energy X‐ray densitometry (DXA) post‐renal transplantation was performed. Aetiology of end stage kidney disease (ESKD), duration of dialysis, parathyroidectomy history, immunosuppression regimen, bone mineral density (BMD), biochemistry and fractures were documented. Statistical analyses included univariable and multivariable regression.Results: The mean age of patients was 54 years and mean time post‐transplantation 6.7 years. A total of 79 fractures occurred in 52 patients (35%), with 40 fractures occurring post‐transplantation. Ankle/foot fractures were most common (48%). Lower serum phosphorus levels and declining femoral neck (FN) T‐score and were associated with fractures in both univariable and multivariable regression analyses after adjusting for age, gender, weight, estimated glomerular filtration rate and pre‐transplant history of fracture (P=.011 and P=.042 respectively). The relationship between serum phosphorus and fracture remained significant independent of FN T‐score, parathyroid hormone levels, parathyroidectomy status and prednisolone use.Conclusion: Fracture was common post‐renal transplantation. Lower serum phosphorus levels and declining FN T‐scores were associated with fractures. The mechanism of this previously unreported observation requires further evaluation in prospective studies.Keywords
Funding Information
- National Health and Medical Research Council
- State Government of Victoria
This publication has 32 references indexed in Scilit:
- Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantationBone, 2012
- Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantationPediatric Transplantation, 2010
- Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: Role of calcium-sensing receptor polymorphisms and vitamin D deficiencyJournal of Bone and Mineral Research, 2010
- Post-renal transplantation hypophosphatemiaPediatric Nephrology, 2009
- Risk of Fractures After Renal Transplantation in the United StatesTransplantation, 2009
- Recovery of Hyperphosphatoninism and Renal Phosphorus Wasting One Year after Successful Renal TransplantationClinical Journal of the American Society of Nephrology, 2008
- Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In VitroJournal of Bone and Mineral Research, 2008
- Elevated calcium phosphate product after renal transplantation is a risk factor for graft failureClinical Transplantation, 2007
- Tertiary ‘Hyperphosphatoninism’ Accentuates Hypophosphatemia and Suppresses Calcitriol Levels in Renal Transplant RecipientsAmerican Journal of Transplantation, 2007
- Bone mineral density and fracture prevalence in long-term kidney graft recipientsTransplantation, 2002